KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,120,000 | +11.6% | 70,000 | +12.9% | 1.12% | +24.8% |
Q2 2023 | $7,278,800 | +7.0% | 62,000 | -27.1% | 0.90% | -34.3% |
Q1 2023 | $6,805,100 | -25.3% | 85,000 | -26.1% | 1.37% | -28.3% |
Q4 2022 | $9,110,300 | +45.2% | 115,000 | +27.8% | 1.91% | +56.8% |
Q3 2022 | $6,273,000 | +83.1% | 90,000 | +72.5% | 1.22% | +72.9% |
Q2 2022 | $3,426,000 | – | 52,184 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |